|
|
Volumn 2, Issue 1, 2002, Pages 1-11
|
|
The evolving therapy of rheumatic diseases, the future is now.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIRHEUMATIC AGENT;
COMPLEMENT;
INTERLEUKIN 1;
TUMOR NECROSIS FACTOR ALPHA;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
REVIEW;
RHEUMATOID ARTHRITIS;
STEM CELL TRANSPLANTATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANTINEOPLASTIC AGENTS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS;
COMPLEMENT SYSTEM PROTEINS;
HUMANS;
INTERLEUKIN-1;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
STEM CELL TRANSPLANTATION;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0036527072
PISSN: 15680088
EISSN: None
Source Type: Journal
DOI: 10.2174/1568008024606347 Document Type: Review |
|
Times cited : (3)
|
|
References (99)
|
